Vitamin D and osteoporosis in chronic kidney disease
Tóm tắt
Osteoporotic fractures are common in patients with chronic kidney disease (CKD). Morbidity and mortality are higher in CKD patients with a fracture than in the general population. The assessment of bone mineral density for fracture prediction may be useful at all CKD stages. It should be considered when this influences treatment decisions. Vitamin D deficiency is common in patients with CKD, particularly in patients with proteinuria, due to loss of 25-hydroxyvitamin D and its binding protein. Vitamin D supplementation should be prescribed early in the course of renal disease. For treatment and prevention of vitamin D deficiency in CKD patients cholecalciferol 800 IU/day or the equivalent per month is recommended just as in the general population.
Tài liệu tham khảo
Hruska KA, Teitelbaum SL (1995) Renal osteodystrophy. N Engl J Med 333(3):166–174
Malluche HH, Mawad HW, Monier-Faugere MC (2011) Renal osteodystrophy in the first decade of the new millennium: analysis of 630 bone biopsies in black and white patients. J Bone Miner Res 26(6):1368–1376
LaClair RE, Hellman RN, Karp SL, Kraus M, Ofner S, Li Q et al (2005) Prevalence of calcidiol deficiency in CKD: a cross-sectional study across latitudes in the United States. Am J Kidney Dis 45(6):1026–1033
Dey V, Farrah TE, Traynor JP, Spalding EM, Robertson SE, Geddes CC (2017) Symptomatic fracture risk in the renal replacement therapy population. Nephrol Dial Transplant 32(7):1211–1216
Daya NR, Voskertchian A, Schneider AL, Ballew S, DeMarco MM, Coresh J et al (2016) Kidney function and fracture risk: the atherosclerosis risk in communities (ARIC) study. Am J Kidney Dis 67(2):218–226
Nickolas TL, McMahon DJ, Shane E (2006) Relationship between moderate to severe kidney disease and hip fracture in the United States. J Am Soc Nephrol 17(11):3223–3232
Ball AM, Gillen DL, Sherrard D, Weiss NS, Emerson SS, Seliger SL et al (2002) Risk of hip fracture among dialysis and renal transplant recipients. JAMA 288(23):3014–3018
Kim SM, Long J, Montez-Rath M, Leonard M, Chertow GM (2016) Hip fracture in patients with non-dialysis-requiring chronic kidney disease. J Bone Miner Res 31(10):1803–1809
Iimori S, Mori Y, Akita W, Kuyama T, Takada S, Asai T et al (2012) Diagnostic usefulness of bone mineral density and biochemical markers of bone turnover in predicting fracture in CKD stage 5D patients—a single-center cohort study. Nephrol Dial Transplant 27(1):345–351
Naylor KL, Garg AX, Zou G, Langsetmo L, Leslie WD, Fraser LA et al (2015) Comparison of fracture risk prediction among individuals with reduced and normal kidney function. Clin J Am Soc Nephrol 10(4):646–653
West SL, Lok CE, Langsetmo L, Cheung AM, Szabo E, Pearce D et al (2015) Bone mineral density predicts fractures in chronic kidney disease. J Bone Miner Res 30(5):913–919
Yenchek RH, Ix JH, Shlipak MG, Bauer DC, Rianon NJ, Kritchevsky SB et al (2012) Bone mineral density and fracture risk in older individuals with CKD. Clin J Am Soc Nephrol 7(7):1130–1136
Bouillon R, Carmeliet G, Verlinden L, van Etten E, Verstuyf A, Luderer HF et al (2008) Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr Rev 29(6):726–776
Lips P (2001) Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocr Rev 22(4):477–501
Heijboer AC, Blankenstein MA, Kema IP, Buijs MM (2012) Accuracy of 6 routine 25-hydroxyvitamin D assays: influence of vitamin D binding protein concentration. Clin Chem 58(3):543–548
Barake M, Daher RT, Salti I, Cortas NK, Al-Shaar L, Habib RH et al (2012) 25-Hydroxyvitamin D assay variations and impact on clinical decision making. J Clin Endocrinol Metab 97:835–843
Binkley N, Sempos CT (2014) Standardizing vitamin D assays: the way forward. J Bone Miner Res 29(8):1709–1714
Ross AC, Manson JE, Abrams SA, Aloia JF, Brannon PM, Clinton SK et al (2011) The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab 96(1):53–58
van Schoor NM, Knol DL, Deeg DJ, Peters FP, Heijboer AC, Lips P (2014) Longitudinal changes and seasonal variations in serum 25-hydroxyvitamin D levels in different age groups: results of the Longitudinal Aging Study Amsterdam. Osteoporos Int 25(5):1483–1491
Kuchuk NO, van Schoor NM, Pluijm SM, Chines A, Lips P (2009) Vitamin D status, parathyroid function, bone turnover, and BMD in postmenopausal women with osteoporosis: Global perspective. J Bone Miner Res 24:693–701
Lips P, Netelenbos JC, Jongen MJ, van Ginkel FC, Althuis AL, van Schaik CL et al (1982) Histomorphometric profile and vitamin D status in patients with femoral neck fracture. Metab Bone Dis Relat Res 4(2):85–93
Kuchuk NO, Pluijm SM, van Schoor NM, Looman CW, Smit JH, Lips P (2009) Relationships of serum 25-hydroxyvitamin D to bone mineral density and serum parathyroid hormone and markers of bone turnover in older persons. J Clin Endocrinol Metab 94(4):1244–1250
Ooms ME, Roos JC, Bezemer PD, van der Vijgh WJ, Bouter LM, Lips P (1995) Prevention of bone loss by vitamin D supplementation in elderly women: a randomized double-blind trial. J Clin Endocrinol Metab 80(4):1052–1058
Lips P, Graafmans WC, Ooms ME, Bezemer PD, Bouter LM (1996) Vitamin D supplementation and fracture incidence in elderly persons. A randomized, placebo-controlled clinical trial. Ann Intern Med 124(4):400–406
Chapuy MC, Arlot ME, Duboeuf F, Brun J, Crouzet B, Arnaud S et al (1992) Vitamin D3 and calcium to prevent hip fractures in elderly women. N Engl J Med 327(23):1637–1642
Sanders KM, Stuart AL, Williamson EJ, Simpson JA, Kotowicz MA, Young D et al (2010) Annual high-dose oral vitamin D and falls and fractures in older women: a randomized controlled trial. JAMA 303(18):1815–1822
Smith H, Anderson F, Raphael H, Maslin P, Crozier S, Cooper C (2007) Effect of annual intramuscular vitamin D on fracture risk in elderly men and women, a population-based, randomized, double-blind, placebo-controlled trial. Rheumatology 46(12):1852–1857
Lips P, van Schoor NM (2011) The effect of vitamin D on bone and osteoporosis. Best Pract Res Clin Endocrinol Metab 25(4):585–591
Lips P, Gielen E, van Schoor NM (2014) Vitamin D supplements with or without calcium to prevent fractures. Bonekey Rep 3:512
Nigwekar SU, Bhan I, Thadhani R (2012) Ergocalciferol and cholecalciferol in CKD. Am J Kidney Dis 60(1):139–156
Gonzalez EA, Sachdeva A, Oliver DA, Martin KJ (2004) Vitamin D insufficiency and deficiency in chronic kidney disease. A single center observational study. Am J Nephrol 24(5):503–510
Lee YH, Kim JE, Roh YH, Choi HR, Rhee Y, Kang DR et al (2014) The combination of vitamin D deficiency and mild to moderate chronic kidney disease is associated with low bone mineral density and deteriorated femoral microarchitecture: results from the KNHANES 2008–2011. J Clin Endocrinol Metab 99(10):3879–3888
Coen G, Mantella D, Manni M, Balducci A, Nofroni I, Sardella D et al (2005) 25-hydroxyvitamin D levels and bone histomorphometry in hemodialysis renal osteodystrophy. Kidney Int 68(4):1840–1848
Kandula P, Dobre M, Schold JD, Schreiber MJ, Mehrotra R, Navaneethan SD (2011) Vitamin D supplementation in chronic kidney disease: a systematic review and meta-analysis of observational studies and randomized controlled trials. Clin J Am Soc Nephrol 6:50–62